The dilemma of anticancer therapy: Tumor-specific versus immune effects

Blood

Volumn 112, Issue 12, 2008, Pages 4364-4365

  Zitvogel, Laurence ^a   Kroemer, Guido ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; IMATINIB; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE DELTA; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; SORAFENIB; UNCLASSIFIED DRUG;

ABELSON MURINE LEUKEMIA ONCOVIRUS; APOPTOSIS; CANCER CELL DESTRUCTION; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CYTOTOXIC T LYMPHOCYTE; DRUG MECHANISM; DRUG TARGETING; DRUG TREATMENT FAILURE; EFFECTOR CELL; ENZYME INHIBITION; ENZYME REGULATION; HOST CELL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; KNOCKOUT MOUSE; LEUKEMIA; LEUKEMIA CELL; NATURAL KILLER CELL; NONHUMAN; NOTE; PRIORITY JOURNAL; TUMOR IMMUNITY;

EID: 61849085817     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-09-176693     Document Type: Note

References (7)

1. Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G. Immunological aspects of cancer chemotherapy. Nat Rev Immunol. 2008;8:59-73.
2. Gasser S, Orsulic S, Brown EJ, Raulet DH. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 2005;436: 1186-1190.
3. Obeid M, Tesniere A, Ghiringhelli F, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med. 2007;13:54-61.
4. Borg C, Terme M, Taieb J, et al. Novel modeof action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects. J Clin Invest. 2004;114: 379-388.
5. Taieb J, Chaput N, Menard C, et al. A novel dendritic cell subset involved in tumor immunosurveillance. Nat Med. 2006;12:214-219.
6. Hipp MM, Hilf N, Walter S, et al. Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses. Blood. 2008;111: 5610-5620.
7. Camps M, Ruckle T, Ji H, et al. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med. 2005;11: 936-943.